基于液相色谱与质谱联用的代谢组学及磷脂轮廓分析在糖代谢异常研究中的应用

糖代谢异常由于其发病率的升高和影响人类的生活质量而日益受到科学研究者的关注。实验中利用液相色谱与质谱(LC-MS)联用技术对糖代谢异常分别进行了代谢组学和磷脂轮廓分析,研究了糖代谢异常中的两个阶段——空腹血糖受损(IFG)和初诊糖尿病(NDD)的代谢差异情况。首先从LC-MS采集到血浆中代谢组学分析及磷脂轮廓分析的原始谱图,通过软件的峰匹配等步骤得到峰表,之后利用多种统计分析方法进行数据分析,通过正交校正的偏最小二乘法(OSC-PLS)对样品进行分型,根据模型的变量重要因子(VIP)、显著性差异检验结果等筛选出差异性代谢物。结果显示: NDD组比IFG组与对照组(N组)比较存在更明显的代谢差异,发生变化的化合物主要为游离脂肪酸、溶血磷脂酰胆碱、磷脂酰乙醇胺、鞘磷脂和磷脂酰胆碱等。     

一种基于液相色谱-质谱技术进行血清代谢组学研究的方法：从代谢指纹到潜在标志物

本文描述了一种基于液相色谱-质谱技术（LC-MS）的代谢组学发现疾病潜在标志物的方法.该方法利用LC-MS获得代谢指纹图谱,并通过多种统计分析方法对产生的海量数据进行分析,最终筛选出潜在标志物.数据分析过程包括：通过归一化、修正80%规则、数据集分割和数据缩放等方法对数据集进行预处理 通过正交校正的偏最小二乘（OPLS）模式识别方法对样品进行分型 根据模型的变量重要性因子（VIP值）、非参数检验结果和z值筛选潜在标志物.以宫颈癌血清样本为例,应用上述方法,15个变量被确认为潜在标志物,操作者接受曲线（ROC）下的面积为0.667～0.956.经过相关性分析和结构鉴定,发现这15个变量来自9个化合物.其中7个化合物被鉴定为色氨酸、硬脂酸、花生四烯酸、溶血磷脂酰胆碱（0：0/16：0,16：0/0：0,18：1/0：0和18：0/0：0）,说明在宫颈癌中花生四烯酸和溶血磷脂酰胆碱的代谢发生异常.     

台风过后网箱养殖大黄鱼恢复过程中血清代谢物变化的研究

为了考察台风影响后鱼类恢复过程中血清代谢物的变化,利用超高效液相色谱-四极杆-飞行时间质谱,电喷雾电离源分别在正负离子模式下,对超强台风"罗莎"影响后的象山港网箱养殖大黄鱼血清进行为期半个月的测定,并通过SIMCA-P软件进行主成分分析和正交偏最小二乘法辨别分析.结果表明,大黄鱼恢复过程中潜在生物标志物主要为磷脂酰胆碱和溶血磷脂酰胆碱.另外还有皮五醇和牛黄胆酸.其中,溶血磷脂酰胆碱、含高不饱和度脂肪酰基的磷脂酰胆碱(总不饱和度之和大于9)和牛黄胆酸在恢复过程中均呈现增加的趋势; 而含低不饱和度脂肪酰基的磷脂酰胆碱(总不饱和度之和小于8)和皮五醇则呈现减少的趋势.这些代谢指标物的变化,体现了大黄鱼在台风后恢复过程中,通过皮质类激素调节脂类物质代谢的结果.     

改性苯乙烯-马来酸酐共聚物色谱固定相用于磷脂分离分析北大核心CSCD

磷脂是重要的信号分子,磷脂的代谢与多种疾病密切相关。因此,开展磷脂的分离分析研究至关重要。苯乙烯-马来酸酐共聚物(SMA)作为一种新型两亲性交替共聚物可以插入生物膜的磷脂双分子层中,形成以膜蛋白质为中心的脂质纳米盘,对膜蛋白质和磷脂具有良好的增溶作用。本文基于“点击”反应和自由基聚合反应,将对磷脂具有良好增溶性能的SMA接枝到硅胶表面,然后以蛋氨酸甲酯盐酸盐(MME·HCl)为开环试剂,通过亲核开环反应对SMA进行修饰,制备了新型的改性SMA修饰色谱固定相(Sil-SMA-MME)。结合高效液相色谱-紫外检测法,利用酰胺类和核苷/核酸碱基类以及苯酚类3类小分子物质对填充Sil-SMA-MME色谱柱的保留机制和分离性能进行了系统评价,Sil-SMA-MME色谱柱具有典型的亲水作用保留机制,其柱效最高可达90900 N/m,并显示了良好的分离选择性。进一步结合高效液相色谱-蒸发光散射检测法,考察了Sil-SMA-MME色谱柱对磷脂样品的分离性能。二棕榈酰磷脂酰丝氨酸钠(DPPS)、二油酰磷脂酰胆碱(DOPC)、二棕榈酰磷脂酰乙醇胺(DPPE)和4种磷脂酰胆碱(PC)类标准品溶血卵磷脂(LysoPC)、二肉豆蔻酰磷脂酰胆碱(DMPC)、二硬脂酰磷脂酰胆碱(DSPC)、二棕榈酰磷脂酰胆碱(DPPC)均可实现基线分离,并且成功地实现了南极磷虾油和人血清磷脂提取物的分离分析。以上结果表明,所制备的Sil-SMA-MME色谱柱在磷脂类物质分离分析中具有良好的应用潜力。     

液相色谱-质谱联用系统在肝硬化不同阶段代谢轮廓研究中的应用

采用高效液相色谱-轨道离子阱质谱联用(HPLC-LTQ Orbitrap XL MS)代谢组学研究平台分析不同阶段肝硬化病人和健康人群的血清标本,获取代谢轮廓。采用模式识别方法结合非参数检验对数据进行分析。研究发现,由肝硬化A级组、B级组、C级组和健康对照组的代谢轮廓构建的正交偏最小二乘判别分析(OPLS-DA)模型(R2（Y）=90.1%, Q2=66.7%),对检测组数据的预测准确率达到93.8%,具有很好的判别能力。从代谢轮廓中可以鉴别出用于区分不同疾病阶段的特异性代谢标志物,如溶血磷脂酰胆碱、甘氨鹅去氧胆酸、半胱氨酸、甘氨酸、氨基己二酸、哌可酸等。研究结果表明: 利用代谢组学方法获得的血清代谢轮廓可以用来构建区分模型和寻找代谢标志物,为乙肝肝硬化的诊断和监测提供支持和依据。     

基于鸟枪法脂质组学研究环氧酶-2抑制剂对关节炎模型血清脂代谢的干预作用

心血管疾病(CVD)是类风湿关节炎(RA)患者死亡的重要原因之一,脂代谢紊乱与CVD发生有密切关联,因而有必要对RA和药物治疗导致的脂代谢改变进行探讨。该研究采用胶原诱导法(CIA)构建关节炎模型,引入多维质谱鸟枪法开展血清脂质分析,检测了血清中105种脂质分子,发现模型大鼠体内7种磷脂酰肌醇、15种鞘磷脂、5种神经酰胺、10种磷脂酰胆碱和2种溶血磷脂酰胆碱异常上调,环氧酶-2(COX-2)抑制剂可部分修复紊乱的脂代谢,但对5种磷脂酰胆碱和1种溶血磷脂酰胆碱具有异常调控作用。该研究从脂质分子水平探讨了RA及COX-2抑制剂对脂代谢的干预作用,可以为RA的心血管风险研究提供信息。     

阳虚体质者血清和尿液的核磁共振代谢组学

采用基于核磁共振(NMR)的代谢组学方法研究了中医阳虚体质及平和体质(正常对照)的血清和尿液, 分析了阳虚体质的特征代谢物. 实验收集阳虚体质及平和体质各30人的血清及尿液样品, 采用多元统计分析方法研究了阳虚质组和对照组血清和尿液中的内源性代谢差异. 结果表明, 阳虚质血清中乳酸、 极低密度脂蛋白/低密度脂蛋白、N-乙酰糖蛋白、脂肪酸及不饱和脂肪酸的含量降低, 谷氨酰胺、葡萄糖、磷脂酰胆碱及高密度脂蛋白的含量增多; 尿液中肌酐的含量降低, 乳酸、二甲胺、柠檬酸及马尿酸的含量增多. 阳虚体质的潜在生物标志物的发现从代谢组学角度为个体差异提供了新的依据. 阳虚体质与平和体质存在能量代谢、脂代谢及糖代谢的差异以及相关脏腑功能的改变.     

基于超高效液相色谱－四极杆－静电场轨道阱质谱的结直肠癌患者血清脂质组学研究

该研究采用超高效液相色谱－四极杆－静电场轨道阱质谱结合主成分分析（PCA）、正交偏最小二乘判别分析（OPLS－DA）对结直肠癌（CRC）患者和健康人的各50例血清样本进行脂质组学分析,通过P < 0.05和倍数变化 > 1.5或 < 0.67筛选组间差异脂质,利用受试者工作特征曲线（ROC）验证其诊断能力,为基于脂质组学的CRC筛查提供参考。结果表明,两组血清脂质谱存在明显差异,发现155种差异脂质,以磷脂酰胆碱（PC）和甘油三酯（TAG）为主,涉及磷脂酰胆碱代谢和甘油三酯代谢。筛选并鉴定9个脂质标志物,包括棕榈酰乙醇胺、棕榈酸、鞘氨醇、鞘磷脂（SM）d40∶3、SM d36∶0、TAG 58∶1、PC 34∶2、PC 36∶6、PC 38∶7,其ROC曲线面积（AUC）均大于0.80,特异性与灵敏度较高,对于CRC筛查具有较高的临床诊断价值和应用潜力。     

亲水作用色谱/质谱联用方法用于膀胱癌患者血清代谢组学研究

膀胱癌是泌尿系统最常见的恶性肿瘤之一,具有高发病率、高复发率和高进展率的特点.本研究应用69个极性代谢物标样选择合适的分离系统,建立了两性离子亲水作用色谱/质谱联用的代谢组学分析方法.本方法线性范围较宽,检出限低于ng/mL数量级.将本方法用于血清代谢组学分析,85%以上代谢物峰面积的RSD<30%.对64例膀胱癌患者和32例正常人的血清进行代谢组学研究,发现溶血磷脂酰胆碱、游离脂肪酸、氨基酸、胆汁酸、有机酸、核苷等在患病组和正常组中存在显著差异.经筛选和验证,甘磷酸胆碱、胱氨酸、十二碳烯酸、二十碳烯酸和鹅去氧胆酸5种代谢物可以作为区分膀胱癌和正常人的潜在标志物.本研究结果表明,基于亲水作用色谱/质谱联用的代谢组学方法是发现癌症诊断潜在生物标志物的有效手段.     

二苯基庚烷A干预RAW264.7细胞炎症模型甘油磷脂的UPLC-Q/TOF MS分析

对RAW264.7细胞在不同状态(正常、炎症、给药)下的甘油磷脂成分进行分析,寻找相关的潜在病理药理标志物,阐明二苯基庚烷A在抗炎过程中对甘油磷脂代谢的影响。实验分为空白组(C)、炎症模型组(L)、二苯基庚烷A给药组(D)和布洛芬给药组(B,阳性对照药组)4组。空白组和炎症组给予新鲜培养基,给药组分别给予新配含20μg/m L二苯基庚烷A和100μg/m L布洛芬的培养基,1 h后,炎症模型组和给药组按终浓度为0.5μg/m L加入脂多糖(LPS)培养,24 h后,运用修饰后的Bligh-Dyer方法提取不同状态下RAW264.7细胞的甘油磷脂成分,并通过超高效液相色谱-四极杆飞行时间质谱联用技术(UPLC-Q/TOF MS)在正负离子模式下对甘油磷脂进行一级(MS)和二级(MS/MS)质谱分析。结合二级质谱裂解数据、元素组成、数据库比对等方法鉴定磷脂成分,再通过主成分分析法(PCA)、偏最小二乘判别分析(PLS-DA)、正交偏最小二乘判别分析(OPLS-DA)以及t检验筛选潜在的甘油磷脂生物标志物。结果显示,炎症组与空白组比较得到27个潜在病理标志物,二苯基庚烷A给药组与炎症组比较得到23个潜在药理标志物,布洛芬给药组与炎症组比较得到17个潜在药理标志物,主要包括磷脂酰胆碱(PC)、溶血磷脂酰胆碱(lyso PC)、磷脂酰乙醇胺(PE)、溶血磷脂酰乙醇胺(lyso PE)。研究表明二苯基庚烷A在抗炎过程中引起了甘油磷脂代谢的明显变化,而这些代谢变化与炎症的发生发展密切相关。     

A Coculture Based, 3D Bioprinted Ovarian Tumor Model Combining Cancer Cells and Cancer Associated Fibroblasts

Ovarian cancer remains a major public health issue due to its poor prognosis. To develop more effective therapies, it is crucial to set-up reliable models that closely mimic the complexity of the ovarian tumor's microenvironment. 3D bioprinting is currently a promising approach to build heterogenous and reproducible cancer models with controlled shape and architecture. However, this technology is still poorly investigated to model ovarian tumors. In this study, a 3D bioprinted ovarian tumor model combining cancer cells (SKOV-3) and cancer associated fibroblasts (CAFs) are described. The resulting tumor models show their ability to maintain cell viability and proliferation. Cells are observed to self-assemble in heterotypic aggregates. Moreover, CAFs are observed to be recruited and to circle cancer cells reproducing an in vivo process taking place in the tumor microenvironment. Interestingly, this approach also shows its ability to rapidly generate a high number of reproducible tumor models that can be subjected to usual characterizations (cell viability and metabolic activity; histology and immunological studies; and real-time imaging). Therefore, these ovarian tumor models can be an interesting tool for high throughput drug screening applications.     

AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration

Ovarian cancer is a leading cause of death in women. Early detection of ovarian cancer is essential to decrease mortality. However, the early diagnosis of ovarian cancer is difficult due to a lack of clinical symptoms and suitable molecular diagnostic markers. Thus, identification of meaningful tumor biomarkers with potential clinical application is clearly needed. To search for a biomarker for the early detection of ovarian cancer, we identified human anterior gradient 2 (AGR2) from our systematic analysis of paired normal and ovarian tumor tissue cDNA microarray. We noted a marked overexpression of AGR2 mRNA and protein in early stage mucinous ovarian tumors compared to normal ovarian tissues and serous type ovarian tumors by Western blot analysis and immunohistochemistry. To further elucidate the role of AGR2 in ovarian tumorigenesis, stable 2774 human ovarian cancer cell lines overexpressing AGR2 were established. Forced expression of AGR2 in 2774 cells enhanced the growth and migration of ovarian cancer cells. AGR2 protein was detected in the serum of mucinous ovarian cancer patients by Western blot and ELISA analysis. Thus, AGR2 is a potential biomarker for the diagnosis of mucinous ovarian cancer and an ELISA assay may facilitate the early detection of mucinous ovarian cancer using patient serum.     

A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection

Oxidized nucleosides are biochemical markers for tumors, aging, and neurodegenerative diseases. However, during the last decade, the analytical methods for nucleosides by gas chromatography/mass spectrometry (GC/MS) and high-performance liquid chromatography (HPLC) with single-parameter detectors like electron-capture detection (ECD) have not been sufficiently rapid or reliable to detect nucleosides in urine and to analyze clinical samples. It has been reported (Dudley et al., Rapid Commun Mass Spectrom. 2000; 14: 1200) that liquid chromatography with electrospray mass spectrometry (LC/ESI-MS) is more specific and sensitive for analysis of nucleosides than HPLC with conventional detectors; however, this method required complex extraction steps. In the present work a direct LC/ESI-MS method for nucleosides without extraction of urine samples has been developed. Analysis of nucleosides using positive-ion mode with selected reaction monitoring effectively eliminated potential interferences from endogenous constituents of the urine. This highly selective and sensitive method made it possible to analyze urinary nucleosides with a lower limit of quantitation of 0.2 nmol/mL. The method has been validated, with both excellent linearity and reproducibility, in the calibration range from 0.2-400 nmol/mL. The correlation coefficients of the calibration curves were higher than 0.987. The coefficients of variation were in the range 0.03-14.92% (inter-day) and 0.54-14.39% (intra-day), respectively.     

Development of a method for simultaneous determination of eflucimibe and its three major metabolites in rat plasma by liquid chromatography/electrospray tandem mass spectrometry: a preliminary study

A high-performance liquid chromatography/electrospray ionisation tandem mass spectrometry (HPLC/ESI-MS/MS) method has been developed for the simultaneous determination of eflucimibe, a powerful acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor, and its main metabolites, in plasma. The ESI and MS/MS parameters were investigated and optimised for each of the four compounds in the positive ion mode. Plasma samples were deproteinised by precipitation with acetonitrile and directly analysed by HPLC/ESI-MS/MS in less than 4 min. Quantitation was performed in the multiple reaction monitoring (MRM) mode for highest sensitivity, selecting the protonated molecules [M+H](+) as precursor ions. The method was demonstrated to be specific and sensitive, and a linear response was observed within a 1-25 ng/mL concentration range. Correlation coefficients (r(2)) greater than 0.9960 were obtained by least-squares regression, and limits of detection down to 0.2 ng/mL were calculated. Therefore, this HPLC/ESI-MS/MS method appears to be an efficient tool, able to provide valuable information for a pharmacological purpose.     

Determination of Tripamide in human urine by high-performance liquid chromatography and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry

Tripamide is a drug widely used in clinical practice for the treatment of hypertension and edema. This work evaluated a screening method for Tripamide and its urinary metabolites in human urine, using high-performance liquid chromatography diode-array detection (HPLC/DAD). Identification of these metabolites was investigated by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ESI-MS/MS) after dosing with 15 mg Tripamide. Acid hydrolysis showed that Tripamide is conjugated in the body. Two suspected metabolites were detected by HPLC/DAD. HPLC/ESI-MS/MS analysis suggested that these metabolites were probably hydroxylated together with loss of the -NH(2) group and dehydrogenation. These results will be useful in confirmation methods for Tripamide in doping control.     

Detection of new radiation-induced DNA lesions by liquid chromatography coupled to tandem mass spectrometry

High-performance liquid chromatography coupled to electrospray ionization tandem mass spectrometry (HPLC/ESI-MS/MS) has been used to search for the formation of as yet unidentified radiation-induced DNA lesions. For that purpose, the characteristic fragmentation of most of 2'-deoxyribonucleosides that corresponds to the loss of the 2-deoxyribose moiety (loss of 116 mass units) has been utilized to specifically detect modified nucleosides. Aerated aqueous solutions of DNA were exposed to ionizing radiation, and subsequently DNA was digested to nucleosides with a cocktail of endo- and exonucleases. HPLC/ESI-MS/MS analysis of the resulting 2'-deoxyribonucleoside mixture allowed us to detect four novel DNA modifications. In a subsequent step, the sensitivity of the tandem mass spectrometer was used to search for the formation of the newly detected lesions in the DNA of gamma-irradiated cells. Thus, one of the four newly detected lesions was found to be significantly generated in cellular DNA upon exposure to ionizing radiation. In addition, the latter lesion was also shown to be present in untreated cells, indicating that the modified nucleoside could be formed endogenously.     

Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models

Ovarian cancer often has a poor clinical prognosis because of late detection, frequently after metastatic progression, as well as acquired resistance to taxane-based therapy. Herein, we evaluate a novel class of covalent microtubule stabilizers, the C-22,23-epoxytaccalonolides, for their efficacy against taxane-resistant ovarian cancer models in vitro and in vivo. Taccalonolide AF, which covalently binds β-tubulin through its C-22,23-epoxide moiety, demonstrates efficacy against taxane-resistant models and shows superior persistence in clonogenic assays after drug washout due to irreversible target engagement. In vivo, intraperitoneal administration of taccalonolide AF demonstrated efficacy against the taxane-resistant NCI/ADR-RES ovarian cancer model both as a flank xenograft, as well as in a disseminated orthotopic disease model representing localized metastasis. Taccalonolide-treated animals had a significant decrease in micrometastasis of NCI/ADR-RES cells to the spleen, as detected by quantitative RT-PCR, without any evidence of systemic toxicity. Together, these findings demonstrate that taccalonolide AF retains efficacy in taxane-resistant ovarian cancer models in vitro and in vivo and that its irreversible mechanism of microtubule stabilization has the unique potential for intraperitoneal treatment of locally disseminated taxane-resistant disease, which represents a significant unmet clinical need in the treatment of ovarian cancer patients.     

Structural analysis of monoterpene glycosides extracted from Paeonia lactiflora Pall. using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry

Paeoniflorin standard was first investigated by electrospray ionization Fourier transform ion cyclotron resonance tandem mass spectrometry (ESI-FTICR-MS/MS) using a sustained off-resonance irradiation (SORI) collision-induced dissociation (CID) method at high mass resolution. The experimental results demonstrated that the unambiguous elemental composition of product ions can be obtained at high mass resolution. Comparing MS/MS spectra and the experimental methods of hydrogen and deuterium exchange, the logical fragmentation pathways of paeoniflorin have been proposed. Then, the extracts of the traditional Chinese medicine Paeonia lactiflora Pall. were analyzed by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ESI-MS/MS). By comparison with the ESI-FTICR-MS/MS data of paeoniflorin, the isomers paeoniflorin and albiflorin in Paeonia lactiflora Pall. have been identified using HPLC/MS with CID in an ion trap and in-source CID. Furthermore, using the characteristic fragmentation pathways, the retention times (t(R)) in HPLC and MS/MS spectra, the structures of three other kinds of monoterpene glycoside compounds have been identified on-line without time-consuming isolation. Thus an HPLC/ESI-MS method for the analysis of constituents in Paeonia lactiflora Pall. has been established.     

HPTLC/DESI-MS imaging of tryptic protein digests separated in two dimensions

Desorption electrospray ionization mass spectrometry (DESI-MS) was demonstrated as a method to detect and identify peptides from two-dimensional separations of cytochrome c and myoglobin tryptic digests on ProteoChrom HPTLC Cellulose sheets. Data-dependent tandem mass spectra were acquired during lane scans across the TLC plates. Peptides and the corresponding proteins were identified using a protein database search software. Two-dimensional distributions of identified peptides were mapped for each separated protein digest. Sequence coverages for cytochrome c and myoglobin were 81 and 74%, respectively. These compared well with those determined using the more standard HPLC/ESI-MS/MS approach (89 and 84%, respectively). Preliminary results show that use of more sensitive instrumentation has the potential for improved detection of peptides with low R(f) values and improvement in sequence coverage. However, less multiple charging and more sodiation were seen in HPTLC/DESI-MS spectra relative to HPLC/ESI-MS spectra, which can affect peptide identification by MS/MS. Methods to increase multiple charging and reduce the extent of sodiation are currently under investigation.